The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Human Papillomavirus DNA versus Papanicolaou Screening Tests for Cervical Cancer
Abstract
BACKGROUND: To determine whether testing for DNA of oncogenic human papillomaviruses (HPV) is superior to the Papanicolaou (Pap) test for cervical-cancer screening, we conducted a randomized trial comparing the two methods. METHODS: We compared HPV testing, using an assay approved by the Food and Drug Administration, with conventional Pap testing as a screening method to identify high-grade cervical intraepithelial neoplasia in women ages 30 to 69 years in Montreal and St. John's, Canada. Women with abnormal Pap test results or a positive HPV test (at least 1 pg of high-risk HPV DNA per milliliter) underwent colposcopy and biopsy, as did a random sample of women with negative tests. Sensitivity and specificity estimates were corrected for verification bias. RESULTS: A total of 10,154 women were randomly assigned to testing. Both tests were performed on all women in a randomly assigned sequence at the same session. The sensitivity of HPV testing for cervical intraepithelial neoplasia of grade 2 or 3 was 94.6% (95% confidence interval [CI], 84.2 to 100), whereas the sensitivity of Pap testing was 55.4% (95% CI, 33.6 to 77.2; P=0.01). The specificity was 94.1% (95% CI, 93.4 to 94.8) for HPV testing and 96.8% (95% CI, 96.3 to 97.3; P<0.001) for Pap testing. Performance was unaffected by the sequence of the tests. The sensitivity of both tests used together was 100%, and the specificity was 92.5%. Triage procedures for Pap or HPV testing resulted in fewer referrals for colposcopy than did either test alone but were less sensitive. No adverse events were reported. CONCLUSIONS: As compared with Pap testing, HPV testing has greater sensitivity for the detection of cervical intraepithelial neoplasia. (Current Controlled Trials number, ISRCTN57612064 [controlled-trials.com].).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Global Cancer Statistics, 2002
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.2.74 · Cited by 18,196
The 2001 Bethesda System<SUBTITLE>Terminology for Reporting Results of Cervical Cytology</SUBTITLE>
Solomon, D. (2002) · JAMA · doi:10.1001/jama.287.16.2114 · Cited by 3,104
Quadrivalent Vaccine against Human Papillomavirus to Prevent High-Grade Cervical Lesions
(2007) · New England Journal of Medicine · doi:10.1056/nejmoa061741 · Cited by 2,055
Harper, D. M., Franco, E. L., Wheeler, C. M., Moscicki, A.-B., Romanowski, B., Roteli-Martins, C. M., Jenkins, D., Schuind, A., Costa Clemens, S. A., & Dubin, G. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68439-0 · Cited by 1,632
Self-citationVilla, L. L., Costa, R. L., Petta, C. A., Andrade, R. P., Ault, K. A., Giuliano, A. R., Wheeler, C. M., Koutsky, L. A., Malm, C., Lehtinen, M., et al. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70101-7 · Cited by 1,579
Self-citation2001 Consensus Guidelines for the Management of Women With Cervical Cytological Abnormalities
Wright, Jr. (2002) · JAMA · doi:10.1001/jama.287.16.2120 · Cited by 1,215
Cuzick, J., Clavel, C., Petry, K., Meijer, C. J. L. M., Hoyer, H., Ratnam, S., Szarewski, A., Birembaut, P., Kulasingam, S., Sasieni, P., et al. (2006) · International Journal of Cancer · doi:10.1002/ijc.21955 · Cited by 1,141
Self-citationSolomon, D., Schiffman, M., & Tarone, R. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.4.293 · Cited by 975
American Cancer Society Guidelines for the Early Detection of Cancer, 2006
Smith, R. A., Cokkinides, V., & Eyre, H. J. (2006) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.56.1.11 · Cited by 639
Manos, M. M., Kinney, W. K., Hurley, L. B., Sherman, M. E., Shieh-Ngai, J., Kurman, R. J., Ransley, J. E., Fetterman, B. J., Hartinger, J. S., McIntosh, K. M., et al. (1999) · JAMA · doi:10.1001/jama.281.17.1605 · Cited by 568
Schiffman, M., Herrero, R., Hildesheim, A., Sherman, M. E., Bratti, M., Wacholder, S., Alfaro, M., Hutchinson, M., Morales, J., Greenberg, M. D., et al. (2000) · JAMA · doi:10.1001/jama.283.1.87 · Cited by 540
Chapter 9: Clinical applications of HPV testing: A summary of meta-analyses
Arbyn, M., Sasieni, P., Meijer, C. J. L. M., Clavel, C., Koliopoulos, G., & Dillner, J. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.05.117 · Cited by 539
Management of women who test positive for high-risk types of human papillomavirus: the HART study
Cuzick, J., Szarewski, A., Cubie, H., Hulman, G., Kitchener, H., Luesley, D., McGoogan, E., Menon, U., Terry, G., Edwards, R., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14955-0 · Cited by 510
Wright, T. C., Schiffman, M., Solomon, D., Cox, J. T., Garcia, F., Goldie, S., Hatch, K., Noller, K. L., Roach, N., Runowicz, C., et al. (2004) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000109426.82624.f8 · Cited by 499
Clavel, C., Masure, M., Bory, J.-P., Putaud, I., Mangeonjean, C., Lorenzato, M., Nazeyrollas, P., Gabriel, R., Quereux, C., & Birembaut, P. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1845 · Cited by 465
Kulasingam, S. L., Hughes, J. P., Kiviat, N. B., Mao, C., Weiss, N. S., Kuypers, J. M., & Koutsky, L. A. (2002) · JAMA · doi:10.1001/jama.288.14.1749 · Cited by 452
Management of women who test positive for high-risk types of human papillomavirus: the HART study
(2004) · Obstetrics & Gynecology · doi:10.1097/00006250-200404000-00038 · Cited by 427
Belinson, J., Qiao, Y. L., Pretorius, R., Zhang, W. H., Elson, P., Li, L., Pan, Q. J., Fischer, C., Lorincz, A., & Zahniser, D. (2001) · Gynecologic Oncology · doi:10.1006/gyno.2001.6370 · Cited by 337
Ronco, G., Segnan, N., Giorgi-Rossi, P., Zappa, M., Casadei, G. P., Carozzi, F., Palma, P. D., Del Mistro, A., Folicaldi, S., Gillio-Tos, A., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj209 · Cited by 313
Petry, K.-U., Menton, S., Menton, M., van Loenen-Frosch, F., de Carvalho Gomes, H., Holz, B., Schopp, B., Garbrecht-Buettner, S., Davies, P., Boehmer, G., et al. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600918 · Cited by 300
HPV testing in primary screening of older women
Cuzick, J., Beverley, E., Ho, L., Terry, G., Sapper, H., Mielzynska, I., Lorincz, A., Chan, W.-K., Krausz, T., & Soutter, P. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690730 · Cited by 268
2001 Consensus Guidelines for the Management of Women with Cervical Cytological Abnormalities
Wright, T. C., Cox, J. T., Massad, L. S., Twiggs, L. B., & Wilkinson, E. J. (2002) · Journal of Lower Genital Tract Disease · doi:10.1097/00128360-200204000-00012 · Cited by 255
Human papillomavirus testing for primary screening of cervical cancer precursors.
Ratnam, S., Franco, E. L., & Ferenczy, A. S. (2000) · PubMed · Cited by 240
Self-citationChapter 20: Issues in planning cervical cancer screening in the era of HPV vaccination
Franco, E. L., Cuzick, J., Hildesheim, A., & de Sanjosé, S. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.05.061 · Cited by 236
Self-citationRonco, G., Giorgi-Rossi, P., Carozzi, F., Dalla Palma, P., Del Mistro, A., De Marco, L., De Lillo, M., Naldoni, C., Pierotti, P., Rizzolo, R., et al. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70731-8 · Cited by 225
Schneider, A., Hoyer, H., Lotz, B., Leistritza, S., Kühne-Heid, R., Nindl, I., Müller, B., Haerting, J., & Dürst, M. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20001120)89:6<529::aid-ijc11>3.0.co;2-g · Cited by 222
Human Papillomavirus DNA Testing for Cervical Cancer Screening in Low-Resource Settings
Kuhn, L., Denny, L., Pollack, A., Lorincz, A., Richart, R. M., & Wright, T. C. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.10.818 · Cited by 217
Cuzick, Sasieni, Davies, Adams, Normand, Frater, van Ballegooijen, & van den Akker (1999) · Health Technology Assessment · doi:10.3310/hta3140 · Cited by 204
Assessing the costs of healthcare technologies in clinical trials.
Johnston, K., Buxton, M. J., Jones, & Fitzpatrick, R. M. (1999) · Health Technology Assessment · doi:10.3310/hta3060 · Cited by 183
Chapter 13: Current findings from prophylactic HPV vaccine trials
Koutsky, L. A., & Harper, D. M. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.06.014 · Cited by 149
Belinson, J. L., Qiao, Y., Pretorius, R. G., Zhang, W. H., Rong, S. D., Huang, M., Zhao, F., Wu, L., Ren, S., Huang, R., et al. (2003) · International Journal of Gynecological Cancer · doi:10.1111/j.1525-1438.2003.13611.x · Cited by 148
Chapter 10: New dimensions in cervical cancer screening
Cuzick, J. M., Mayrand, M., Ronco, G., Snijders, P. J. F., & Wardle, J. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.05.122 · Cited by 146
Self-citationWomen's desired information about human papillomavirus
Anhang, R., Wright, T. C., Smock, L., & Goldie, S. J. (2004) · Cancer · doi:10.1002/cncr.20007 · Cited by 131
Mayrand, M., Duarte‐Franco, E., Coutlée, F., Rodrigues, I., Walter, S. D., Ratnam, S., Franco, E. L., & for the CCCaST Study Group (2006) · International Journal of Cancer · doi:10.1002/ijc.21897 · Cited by 122
Self-citationBlumenthal, P. D., Gaffikin, L., Chirenje, Z. M., McGrath, J. A., Womack, S. D., & Shah, K. V. (2001) · International Journal of Gynecology & Obstetrics · doi:10.1016/s0020-7292(00)00329-5 · Cited by 103
Does Liquid-Based Technology Really Improve Detection of Cervical Neoplasia?
Obwegeser, J. H., & Brack, S. (2001) · Acta Cytologica · doi:10.1159/000328292 · Cited by 95
Initial results from a randomized trial of cervical visual screening in rural south India
Sankaranarayanan, R., Rajkumar, R., Theresa, R., Esmy, P. O., Mahe, C., Bagyalakshmi, K. R., Thara, S., Frappart, L., Lucas, E., Muwonge, R., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.11726 · Cited by 88
Bidus, M. A., Maxwell, G. L., Kulasingam, S., Rose, G. S., Elkas, J. C., Chernofsky, M. R., & Myers, E. R. (2006) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000210529.70226.0a · Cited by 55
Stoler, M. H. (2003) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2003-127-935-hpbacn · Cited by 50
New dimensions in cervical cancer screening
Cuzick, J. M., Mayrand, M., Ronco, G., Snijders, P. J. F., & Wardle, J. (2006) · UCL Discovery (University College London) · Cited by 38
Self-citationBelinson, J. L., Qiao, Y., Pretorius, R. G., Zhang, W. H., Elson, P. J., Li, L., Pan, Q. J., Fischer, C., Lörincz, A. T., & Zahniser, D. J. (2002) · Gynecologic Oncology · doi:10.1006/gyno.2001.6554 · Cited by 18
Cited by
Ronco, G., Dillner, J., Elfström, K. M., Tunesi, S., Snijders, P. J. F., Arbyn, M., Kitchener, H., Segnan, N., Gilham, C., Giorgi-Rossi, P., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62218-7 · Cited by 1,810
Saslow, D., Solomon, D., Lawson, H. W., Killackey, M., Kulasingam, S. L., Cain, J., Garcia, F. A. R., Moriarty, A. T., Waxman, A. G., Wilbur, D. C., et al. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21139 · Cited by 1,390
Self-citationScreening for cervical cancer: U.S. preventive services Task force recommendation statement
Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force* (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-12-201206190-00424 · Cited by 1,049
Saslow, D., Solomon, D., Lawson, H. W., Killackey, M., Kulasingam, S. L., Cain, J. M., Garcia, F. A. R., Moriarty, A. T., Waxman, A. G., Wilbur, D. C., et al. (2012) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0b013e31824ca9d5 · Cited by 915
Self-citationEvidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer
Arbyn, M., Ronco, G., Anttila, A., Meijer, C. J. L. M., Poljak, M., Ogilvie, G., Koliopoulos, G., Naucler, P., Sankaranarayanan, R., & Peto, J. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.06.095 · Cited by 897
Metadata
- Authors
- Mayrand, M.-H., Duarte-Franco, E., Rodrigues, I., Walter, S. D., Hanley, J., Ferenczy, A., Ratnam, S., Coutlée, F., & Franco, E. L.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2007-10-18
- Volume
- 357
- Issue
- 16
- Pages
- 1579-1588
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2114212562
- Cited by
- 1,100
- References
- 42
- FWCI
- 55.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.